Skip to main content

Closed

LPCN: Lipocine Inc. Financial Statements & Revenue | finqOS

Healthcare · Biotechnology

52W Range

3thpctl

Volume

0.37×avg

Market Cap

12.30MUSD

P/E Ratio

-1.1TTM

Div Yield

-ann

Lipocine Inc.

LPCNNASDAQ Capital Market·USD·Closed

Lipocine Inc.

LPCNNASDAQ·USD·Closed

$2.12

+0.38%

$2.12

+$0.01 (0.38%)

52W Range

3thpctl

Volume

0.37×avg

Mkt Cap

12.30MUSD

P/E

-1.1TTM

Div Yield

–ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings